Dr. Justin Tyme Goranovich, MD

Dr. Goranovich practices at OhioHealth Riverside Methodist Hospital in Columbus, Ohio, part of OhioHealth.

Dr. Goranovich's NPI, 1285054999, was assigned on April 21, 2014. Dr. Goranovich holds Ohio license 35139987.

Dr. Goranovich's primary practice is OhioHealth Riverside Methodist Hospital, at 3535 Olentangy River Rd, Columbus, OH 43214 in Franklin County. The practice phone is (614) 566-5000.

Dr. Goranovich's primary practice is OhioHealth Riverside Methodist Hospital in Columbus, Ohio, part of OhioHealth. Dr. Goranovich is also affiliated with OhioHealth Grant Medical Center. The medical group on file is OhioHealth Physician Group. Dmand AI also links Dr. Goranovich to 1 more hospital, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goranovich practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Goranovich's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Goranovich is licensed in Ohio.

CMS data shows 20 Medicare services from Dr. Goranovich across 1 procedure code in 2024, all of them office visits, for 35 Medicare patients. Medicare paid $2,715 for them. Every service was in an office.

CMS counts 35 Medicare patients who saw Dr. Goranovich in 2024. The largest group is 65 to 74, with 20 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goranovich's median patient age at 64, with 55% women.

In 2024, Dr. Goranovich wrote 150 Medicare Part D claims for 46 patients. 91% of them were for generic drugs. CMS names the drug for 73 of them, across 5 drugs with 11 or more claims each, at $1,598 in total drug cost. In 2023, CMS named 25 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Goranovich for performance year 2024, reported as part of a group. Dr. Goranovich accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Goranovich in 2022. 2022 was the busiest year, with 2. Dr. Goranovich's most frequent co-authors are Sasha J. Beyer, Shirley S. Ong, MD and Joshua D. Palmer, MD.

Dmand AI links Dr. Goranovich to 1 clinical trial. Conditions studied include Brain Neoplasms and Neoplasm Metastasis.

CMS Open Payments shows 2 general payments to Dr. Goranovich from 2 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 100% of the total. Novocure Inc. paid the most, $129.